The study aimed to assess the diagnostic properties of electrocardiographic (ECG) criteria for right ventricular hypertrophy (RVH) measured by cardiac magnetic resonance imaging (cMRI) in adults without clinical cardiovascular disease.
Objectives
The study aimed to assess the diagnostic properties of electrocardiographic (ECG) criteria for right ventricular hypertrophy (RVH) measured by cardiac magnetic resonance imaging (cMRI) in adults without clinical cardiovascular disease.
Background
Current ECG criteria for RVH were based on cadaveric dissection in small studies.
Methods
MESA (Multi-Ethnic Study of Atherosclerosis) performed cMRIs with complete right ventricle (RV) interpretation on 4,062 participants without clinical cardiovascular disease. Endocardial margins of the RV were manually contoured on diastolic and systolic images. The ECG screening criteria for RVH from the 2009 American Heart Association Recommendations for Standardization and Interpretation of the ECG were examined in participants with and without left ventricular (LV) hypertrophy or reduced ejection fraction. RVH was defined using sex-specific normative equations based on age, height, and weight.
Results
The study sample with normal LV morphology and function (n ¼ 3,719) was age 61.3 AE 10.0 years, 53.5% female, 39.6% Caucasian, 25.5% African American, 21.9% Hispanic, and 13.0% Asian. The mean body mass index was 27.9 AE 5.0 kg/m 2 . A total of 6% had RVH, which was generally mild. Traditional ECG criteria were specific (many >95%) but had low sensitivity for RVH by cMRI. The positive predictive values were not sufficiently high as to be clinically useful (maximum 12%). The results did not differ based on age, sex, race, or smoking status, or with the inclusion of participants with abnormal LV mass or function. Classification and regression tree analysis revealed that no combination of ECG variables was better than the criteria used singly.
Conclusions
The recommended ECG screening criteria for RVH are not sufficiently sensitive or specific for screening for mild RVH in adults without clinical cardiovascular disease. Right ventricular hypertrophy (RVH) results from increased right ventricular (RV) afterload from pulmonary hypertension or other heart, lung, or sleep disorders, which are associated with significant morbidity and mortality (1) (2) (3) (4) (5) (6) . As the diagnosis of pulmonary hypertension is frequently delayed (7) , and even mild RVH is an independent predictor of heart failure and cardiovascular death (8) , early detection of RVH could facilitate treatment and potentially improve outcomes (7, 9) . Nonetheless, screening strategies in the general population are limited. Given the complex 3-dimensional anatomical structure of the RV and the frequent difficulty of measuring the thickness of the RV free wall, conventional 2-dimensional echocardiography is a poor quantitative measure of the RV and is relatively expensive (10) (11) (12) (13) (14) . There are recommended electrocardiographic (ECG) criteria for RVH, which could provide a noninvasive, welltolerated, inexpensive method of screening (15) (16) (17) (18) (19) (20) . However, these criteria were derived from cadaveric dissection of selected patients in studies performed over a generation ago and have never been validated. Historically, studies of ECG criteria for right, left, or bilateral ventricular hypertrophy were small in size, were limited to white populations, and (with rare exception) (17, 21) attempted to find ECG correlates of RV pathology in patients with previously diagnosed, clinically advanced cardiopulmonary disease (16, 18, 19, (22) (23) (24) (25) (26) (27) Therefore, ECG criteria for RVH have unclear accuracy in a community-based adult population without known cardiovascular disease (28, 29) .
RV structure and function are difficult to assess with standard transthoracic echocardiography, and although newer research techniques, such as 3-dimensional echocardiography (12, (30) (31) (32) (33) (34) (35) and speckle tracking (36) (37) (38) (39) (40) (41) (42) (43) , overcome some of these limitations, cardiac magnetic resonance imaging (cMRI) accurately measures RV mass without requiring any assumptions about RV morphology. We have previously established normative allometric equations to define RVH as RV mass >95th percentile based on demographics and body size in a normal population, which is generally mild (44) . In this study, we aimed to address whether the American Heart Association (AHA) criteria for RVH (15) apply to RVH detected by cMRI in a large, population-based, multiethnic sample of adults in the community.
Methods
MESA (Multi-Ethnic Study of Atherosclerosis) is a multicenter, prospective cohort study designed to investigate the prevalence, correlates, and progression of subclinical cardiovascular disease in Caucasians, African Americans, Hispanics, and Asian Americans without clinical cardiovascular disease at baseline (45) . In 2000 to 2002, MESA recruited 6,814 men and women, 45 to 84 years of age, from 6 U.S. communities: Forsyth County, North Carolina; Northern Manhattan and the Bronx, New York; Baltimore City and Baltimore County, Maryland; St. Paul, Minnesota; Chicago, Illinois; and Los Angeles, California. All patients gave informed consent for participation in MESA. Exclusion criteria included clinical cardiovascular disease (physiciandiagnosed heart attack, stroke, transient ischemic attack, heart failure, angina, current atrial fibrillation, any cardiovascular procedure), weight >136 kg (300 lb), pregnancy, or impediment to long-term participation. By design, patients with hypertension, diabetes mellitus, and hypercholesterolemia were included as these conditions were not considered clinical cardiovascular disease. Of the 6,814 MESA participants, 5,098 (75%) had cMRIs; 5,004 (73%) were interpretable for left ventricular (LV) measures. MESA-RV (Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study) is an ancillary study that attempted to read 4,484 (66%) cMRIs, of which 4,204 (62%) were available and interpretable for RV morphology. The total number of cMRIs with RV interpretation was limited by grant funding; however, a sufficient number of scans were interpreted to provide enough power to achieve our aims. We sampled the MESA population without regard to demographics or other participant features. Thirty-five participants (<1%) were excluded for lack of ECG data, leaving 4,169 (61%) (Fig. 1) . We also excluded 107 participants (1.6%) with interventricular conduction delay, left bundle branch block, Wolff-ParkinsonWhite syndrome, advanced atrioventricular block, and/or poor-quality ECGs (which were not exclusive), leaving 4,062 (60%) in the study sample.
The protocols of MESA and all studies described herein were approved by the Institutional Review Boards of all collaborating institutions and the National Heart, Lung, and Blood Institute. The National Heart, Lung, and Blood Institute staff participated in the design of MESA. cMRI measures. The MESA cMRI protocol, image analysis, and methods for interpretation of LV and RV parameters have been previously reported (46) (47) (48) (49) . Briefly, cMRI examinations were transmitted to the reading center at Johns Hopkins University in Baltimore, Maryland, with the digital imaging and communications in medicine transfer protocol. Image analysis was performed by 2 experienced readers on Windows (Microsoft, Seattle, Washington) workstations with QMASS software (version 4.2, Medis, Leiden, the Netherlands).
The endocardial and epicardial borders of the RV were traced manually on the short-axis cine images at the endsystolic and -diastolic phases. Full visualization of the correct placement of RV contours relied on evaluation of cine images to determine the demarcation between the right atrium and the RV. Contours were modified at basal slices of the heart by careful identification of the tricuspid valve so as to exclude the right atrium and to avoid overestimation of the volumes. Papillary muscles and trabeculae were included in the RV volumes and excluded from RV mass, as is commonly done for LV mass (50, 51) . RV mass was measured as the sum of the myocardial area (the difference between endocardial and epicardial contours) times slice thickness plus image gap in the end-diastolic phase multiplied by the specific gravity of the myocardium (1.05 g/ml).
The intrareader intraclass correlation coefficient from random, blinded rereads of 229 scans for RV mass was Electrocardiography. Standard 12-lead ECGs were digitally acquired using a Marquette MAC-PC electrocardiograph (Marquette Electronics, Milwaukee, Wisconsin) at 10-mm/mV calibration and speed of 25 mm/s. To minimize interindividual variability in vector detection based on electrode placement, ECG technicians in MESA underwent training in determining anatomic landmarks (i.e., the fourth and fifth intercostal spaces and left midaxillary line) and to use an electrode locator designed to more precisely place lead V 4 at a 45 angle between the midsternal and left midaxillary lines at the fifth intercostal space. Electrodes V 3 and V 5 were placed in a straight line halfway between electrodes V 2 and V 4 , and V 4 and V 6 , respectively. Limb leads were placed on the wrists and ankles. All measurements were automated, and analysis was performed centrally at the EPICARE reading center, Wake Forest University. Furthermore, all ECGs were visually inspected for technical errors and inadequate quality. The ECG criteria of RVH from the 2009 AHA Recommendations for Standardization and Interpretation of the ECG were examined (Table 1) (15) . Independent variables and covariates. Race/ethnicity was self-reported during the baseline MESA examination according to 2000 U.S. Census criteria as race (Caucasian, African American, Asian American) and ethnicity (Hispanic or non-Hispanic). Standard questionnaires were used to ascertain smoking status (classified as never, former, or current) and pack-years. Resting blood pressure was measured 3 times with the Dinamap Monitor PRO 100 (Critikon, Tampa, Florida) automated oscillometric device, and the average of the last 2 measurements was used. Hypertension was defined as systolic blood pressure !140 mm Hg, diastolic blood pressure !90 mm Hg, or selfreported hypertension and current use of antihypertensive medication. Presence of diabetes mellitus was based on selfreported physician diagnosis, use of medication for hyperglycemia, or a fasting glucose value !126 mg/dl, the latter measured by rate reflectance spectrophotometry (Johnson & Johnson Clinical Diagnostics, Inc., Rochester, New York). Fasting glucose between 100 and 125 mg/dl was considered impaired fasting glucose. Fasting blood samples were drawn and sent to a central laboratory for measurement of glucose. Spirometric measures and lung density from computed tomography of the chest (% emphysema) were acquired as described (44) . Statistical analysis. Continuous variables were summarized by mean AE SD and categorical variables by n (%). We determined the sensitivity, specificity, positive predictive values, and negative predictive values of the 2009 AHA ECG criteria for RVH (15) . We performed the primary analysis in those without left ventricular hypertrophy (LVH) ECG Criteria for RV Hypertrophy in the MESA Study February 25, 2014:672-81 or reduced LV ejection fraction, and we performed sensitivity analyses including all participants. We used classification and regression tree (CART) analysis to determine if any combination of the criteria would perform better than the individual criteria. We performed additional analyses of the continuous ECG parameters from the ECG criteria using receiver-operating characteristic curves to determine if there may be different optimal cutoffs.
Detailed derivations of the normative equations used to identify RVH and LVH from a healthy subset of MESA have been published previously (44, 52 , where Ht is height in meters and Wt is weight in kg. We defined RVH as present if RV mass was >126% predicted (95th percentile), which included mild RVH. We performed additional analyses with RVH defined as RV mass >99th percentile.
Results
The study sample for the primary analysis with normal LV morphology and function (n ¼ 3,719) was 61.3 AE 10.0 years of age, 46.5% male, 39.6% Caucasian, 25.5% African American, 21.9% Hispanic, and 13.0% Asian ( Table 2 ). The mean body mass index was 27.9 AE 5.0 kg/m 2 . Participants with LVH or decreased LV ejection fraction were more likely to be male, to be African American, to have hypertension and diabetes, and to be current smokers, and were less likely to be Asian American or college graduates. Age, body mass index, and height were similar between groups; formal statistical testing is not appropriate for such comparisons, which are descriptive rather than inferential (53) . Using sex-specific normative equations, the overall prevalence of RVH in the entire study group was 7.2% (RV mass in RVH: 27.3 AE 4.6 g vs. RV mass with no RVH: 20.5 AE 4.0 g; 6.0% of participants with normal LV morphology had RVH and 19.5% of participants with LVH or decreased LV function had RVH). Characteristics of those with and without RVH are shown in Table 3 .
In participants with normal LV morphology, the majority of ECG criteria for RVH had sensitivities <10% ( Table 4 ). The Lewis criterion from 1914 [(R in lead I þ S in lead III) -(S in lead 1 þ R in lead III) <15 mV] had the highest sensitivity (80.4%), but also the lowest specificity of all of the criteria. Similarly, the "supportive criterion" of S >R in lead III had a sensitivity of 56.7%, but a specificity of only 46.1%. Although other findings were specific, the prevalence of RVH was sufficiently low that the post-test probability of RVH was not significantly different than the pre-test probability even with the presence of the ECG sign. For example, although having an R-peak in V 1 >0.035 s with a QRS <0.12 s had a positive predictive value of 12.0% (95% confidence interval: 5.9% to 21.0%), this was not much different from the pre-test probability of RVH (6%), and the confidence interval included the pre-test probability. Similarly, with negative predictive values of approximately 94% for all ECG criteria, an ECG negative for all AHA criteria for RVH did not significantly alter the pre-test probability for RVH given its low prevalence in this population. CART analysis failed to identify any combination of the previous criteria that was better than the criteria used singly.
We attempted to define new criteria by finding optimal cut points for each wave amplitude. However, the areas under the curves (AUCs) for all wave amplitudes (modeled as continuous variables) were uniformly low in the main study sample (all AUCs 0.55). Furthermore, CART analysis was used to explore the relationships between a combination of the individual wave amplitudes and RVH. There was no combination of the wave variables that was better than the criteria used singly.
The sensitivity, specificity, positive and negative predictive values, and AUCs were essentially unchanged after including patients with LVH and reduced LV ejection fraction (and a higher prevalence of RVH; data not shown). None of the results differed based on age, sex, race, or smoking. Potential cutoffs for mild, moderate, and severe RVH could be as follows: mild RVH >95th percentile and 97th percentile, moderate RVH >97th percentile and 99th percentile, and severe RVH >99th percentile. We performed additional analyses using severe RVH, which was present in 1% of the study sample (RV mass in Table 1 American Heart Association Recommended Criteria for Right Ventricular Hypertrophy by Study Lewis (27) 
Discussion
We have shown that the 2009 AHA recommended ECG criteria for RVH have inadequate sensitivity and specificity in a community-based multiethnic sample of adults without clinical cardiovascular disease and should not be used to screen for mild RVH in this population. Most criteria (including R in lead V 1 >6 mV, S in lead V 5 >10 mV, R in lead V 1 þ S in lead V 5,6 >10.5 mV, and presence of a QR in lead V 1 ) indicated w10% chance of having RVH, which was not much different from the underlying prevalence of RVH in our study sample and, therefore, would not be helpful clinically. Primary analyses were performed in those participants with normal LV morphology; conclusions were similar after including those with LVH or focusing on those with more severe RVH. Current recommended AHA criteria for RVH by surface ECG are based on older studies with small study populations and spectra of disease that may not be pertinent in the modern era in the United States (15) (16) (17) (18) (19) (20) . The test properties of ECG in populations with severe RVH from advanced cardiopulmonary disease are likely not applicable to an asymptomatic outpatient population undergoing routine testing for screening. Ten of 15 screening criteria for RVH were from a single study of 40 patients found to have RVH at autopsy due to cor pulmonale (24), mitral stenosis (13), Tetralogy of Fallot (2), or "arteriovenous aneurysm" (18) . Although specificity was high, measured criteria were insensitive. Furthermore, the determination of RVH was nonstandard (17) . Lewis (27) performed an autopsy study of 33 patients with mitral stenosis (including 17 with concomitant aortic valve disease) revealing that 50% demonstrated the "Einthoven's Sign" (54, 55) 
The preponderance of mitral stenosis and aortic valve lesions make the ECG findings difficult to apply to the general population, including that of MESA, where the positive and negative predictive values of this sign were poor. Sokolow and Lyon (26) studied the presence of an R-wave in aVR >4 mV, reduced R:S in V 5 to R:S in V 1 , and R-wave in V 1 þ S-wave in V 5,6 >10.5 mV in 60 clinically-ill patients (1 month to 70 years of age, 40% were <5 years of age) with cyanotic congenital heart disease (n ¼ 44), chronic obstructive pulmonary disease (n ¼ 8), mitral stenosis (n ¼ 6), kyphoscoliosis (n ¼ 1), or pulmonary fibrosis (n ¼ 1) and 150 healthy controls. Diagnoses of RVH were made by autopsy or surgery in 18 patients with congenital heart disease and by angiocardiogram in 1. An R-wave >4 mV in aVR had a positive predictive value of >30%, which was much higher than that found in our study sample.
Another study included 50 patients with RVH due to mitral stenosis and 500 healthy controls (19) . Hypothesizing that the sum of the anterior, rightward, and posterolateral depolarization forces would be greater in RVH compared with controls, these investigators found that the combination of Table 2 .
JACC
[(maximum of R-wave in V 1 or V 2 ) þ (maximum of S-wave in I or aVL) -(S-wave in V 1 )] !0.7 mV and an R-wave in I 0.2 mV provided a specificity of 94% and sensitivity of 66%, both more sensitive and specific than in the MESA population. These patients were an average of 45 years of age, 88% were female, and all had known clinically-diagnosed valvular disease. In patients with known isolated RVH or biventricular hypertrophy, this criterion was found to be comparably specific but insensitive (16) . A more recent study compared this same criterion to the gold standard of cMRI in 28 patients with known pulmonary arterial hypertension and confirmed high specificity but with similarly low sensitivities of 64% to 71%, depending on the definition of RVH used (56) . Several recent studies have aimed to examine the usefulness of ECG in the diagnosis of RVH as measured by cMRI (56) (57) (58) or elevated pulmonary arterial pressures (59) . Uniformly, in much smaller groups of patients (ranging from n ¼ 23 to n ¼ 38) than our study, various criteria for RVH have been examined, including the AHA recommended criteria. Similar to prior published work, these studies were in patients with known RVH (56) (57) (58) or, based on clinical risk factors, who were at high risk for pulmonary hypertension (59) . Investigators found low sensitivity and insufficient specificity to be clearly useful in identifying RVH. Furthermore, the question of whether changing cutoff values for criteria would be helpful has been raised (57), which our study demonstrates as ineffective in a large, multiethnic population. In a population of 216 individuals at high risk for pulmonary hypertension, Scherptong et al. (59) found a relationship between ventricular gradient (difference in averaged QRS integral and T-wave integral across a 10-s 12-lead ECG) and pulmonary arterial systolic pressures, but this study did not examine RVH.
Interestingly, the AHA criteria for RVH do not include right axis deviation of the QRS complex. The LV mass is much greater than that of the RV and is thought to dominate the vector of ventricular activation, both in patients with LVH and in those with normal hearts. Although hypertrophy of the RV causes displacement of the QRS anteriorly (as seen in the precordial leads) and to the right (as seen in the limb leads), it is thought that marked RVH is required to upset the normal QRS axis. For this reason, right axis deviation is excluded from the AHA recommended criteria for RVH screening (15) .
In diagnosing other diseases of the heart affecting cardiac function or predicting cardiovascular events, ECG has variable performance as a screening tool. Use of ECG as screening in subclinical or stable coronary artery disease is insufficient in sensitivity and is not recommended as a screening tool for atherosclerosis (60) . Nonetheless, the U.S. Preventive Services Task Force has summarized a wealth of large cohort studies on the utility of resting screening ECG as a predictor of cardiovascular events, with regard to ST-segment abnormalities, T-wave abnormalities, ST-or T-wave abnormalities, evidence of LVH, bundle branch blocks, and left axis deviation (61) . Pooled risk estimates of over 30 published studies revealed ST abnormalities (62) (63) (64) (65) (66) and ST-or T-wave abnormalities (64, (67) (68) (69) (70) (71) (72) as the best predictors of future cardiovascular events on screening ECG (77) . No prior large cohort studies have examined the utility of ECG in screening for RVH, whether as a diagnostic or prognostic test. Based on our results, the 2009 AHA criteria should not be used to screen for RVH in community-based multiethnic studies of adults without known clinical cardiovascular disease. Absence of the criteria does not exclude the possibility of RVH and pulmonary hypertension, and RVH will only be present in 1 of 10 individuals who fulfill some of the criteria. This is likely attributable in part to the mostly mild RVH seen in this population, even in those on the extreme end of the spectrum of adults. Commencing a workup in clinical cardiovascular disease-free adults similar to the MESA population with ECG criteria for RVH can not be recommended considering the poor predictive value, the expense of cardiac imaging, the potential distress caused by a spurious diagnosis of RVH (which will not be present in 90% of those who meet criteria) or pulmonary hypertension, the unclear individual prognostic implications, and lack of proven management strategies. In a clinically ill population, or one at increased risk for RVH, the AHA criteria may have clinical or prognostic utility. Furthermore, these ECG findings in a patient presenting acutely with symptoms or with known cardiovascular disease may have distinct implications; the findings of this study may not apply to such populations. Study limitations. By design of the parent study, the study population was free of clinically-diagnosed cardiovascular disease (but included participants with hypertension, diabetes, and hypercholesterolemia, which were not considered clinical heart disease). The exclusion of individuals with clinically-diagnosed heart disease likely selected for those with milder degrees of RVH than may be seen in the general population (spectrum bias). However, the clinical usefulness of screening ECG would be precisely in individuals without a previous diagnosis of significant cardiac disease, making our conclusions more relevant to the population of interest. We defined RVH as the 95th percentile of the indexed RV mass, which is associated with an increase in heart failure and cardiovascular death, validating its use in this study (8) . The test properties of the ECG screening criteria were similar when using a more extreme RVH definition. Last, ECG findings could not be compared with echocardiography, which was not performed. However, traditional transthoracic echocardiography is less accurate for the diagnosis of RVH than cMRI.
Conclusions
The recommended ECG criteria for RVH are inadequate for use as a screening tool in multiethnic adults 45 to 84 years of age without clinical cardiovascular disease.
